Business Context and Reporting Period
Company: Mountain Lake Acquisition Corp. II (MLAC II), a Cayman Islands special purpose acquisition company (SPAC).
Reporting Date: April 9, 2026.
Event: MLAC II and Terra Quantum AG, a quantum technology company, announced the execution of a non-binding letter of intent to enter into a business combination.
Key Financial Metrics
The filing is a Current Report on Form 8-K regarding a material event and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data for the reporting period.
Securities Registered:
- Units (MLAAU): One Class A ordinary share and one-half of one redeemable warrant.
- Class A ordinary shares (MLAA): Par value $0.0001 per share.
- Warrants (MLAAW): Exercisable for one Class A ordinary share at $11.50 per share.
Material Changes
The primary material change is the initiation of merger discussions with Terra Quantum AG. No financial performance changes are reported in this document.
Guidance, Outlook, and Risks
Transaction Status: The proposed business combination is subject to the negotiation of a definitive agreement and satisfaction of customary conditions, including due diligence, board and shareholder approvals, and regulatory clearances. There is no assurance that a definitive agreement will be executed or the transaction consummated.
Future Filings: If a definitive agreement is reached, a registration statement on Form S-4 or F-4 (including a Proxy Statement) will be filed with the SEC.
Key Risks Disclosed:
- Failure to complete the transaction in a timely manner or at all.
- Failure to meet the business combination deadline or obtain an extension.
- Disruption to Terra Quantum's business operations.
- Volatility in MLAC II's securities price.
- Global economic and political conditions, specifically citing the Russia-Ukraine conflict and the U.S. war with Iran.
Investor Verification Checklist
- Verify the execution of a definitive agreement following this non-binding letter of intent.
- Review the upcoming Proxy Statement (Form S-4 or F-4) for transaction terms, valuation, and capital structure details.
- Confirm shareholder approval outcomes for the proposed business combination.
- Monitor regulatory approval status for the merger between MLAC II and Terra Quantum AG.
- Check for any updates regarding the business combination deadline to assess the risk of liquidation.